Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors
Program
Contacts

Merck gets US FDA’s approval for OTC Oxytrol patch

30.01.2013

Merck has received FDA approval for an over-the-counter treatment for overactive bladder, Oxytrol for Women, BusinessWeek reports.

Oxytrol has been on the market since 2003. The company licensed the exclusive commercialization rights regarding Oxytrol for Women from Watson Pharmaceuticals, Inc., which is currently known as Actavis, Inc.

Source: pharmvestnik.ru


Back to the list

exhibitor's opinion
Photo gallary

Invite partners to the exhibition
Facebook Youtube RSS Feed





Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34